Compass Financial Management LLC acquired a new position in shares of Lam Research Corporation (NASDAQ:LRCX – Free Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 8,814 shares of the semiconductor company’s stock, valued at approximately $3,721,000.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in LRCX. Fideuram Asset Management Ireland dac bought a new position in shares of Lam Research during the 4th quarter worth approximately $10,035,000. Rokos Capital Management LLP lifted its position in shares of Lam Research by 42.0% in the first quarter. Rokos Capital Management LLP now owns 259,921 shares of the semiconductor company’s stock worth $55,532,000 after purchasing an additional 76,840 shares in the last quarter. Aware Super Pty Ltd as trustee of Aware Super bought a new stake in shares of Lam Research in the first quarter worth $59,973,000. Krilogy Financial LLC boosted its holdings in Lam Research by 19.5% during the first quarter. Krilogy Financial LLC now owns 28,111 shares of the semiconductor company’s stock worth $6,006,000 after purchasing an additional 4,584 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd bought a new position in Lam Research in the first quarter valued at $26,489,000. 84.61% of the stock is owned by institutional investors and hedge funds.
Lam Research Stock Down 1.2%
Lam Research stock opened at $310.17 on Tuesday. The stock has a market cap of $388.12 billion, a P/E ratio of 53.85, a P/E/G ratio of 1.25 and a beta of 1.84. The company has a quick ratio of 1.91, a current ratio of 2.63 and a debt-to-equity ratio of 0.30. Lam Research Corporation has a twelve month low of $94.11 and a twelve month high of $438.50. The company’s 50-day moving average price is $335.90 and its two-hundred day moving average price is $286.99.
Insider Buying and Selling at Lam Research
In other Lam Research news, Director Abhijit Y. Talwalkar sold 18,282 shares of the stock in a transaction on Monday, July 13th. The stock was sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the transaction, the director owned 87,142 shares in the company, valued at $29,192,570. This trade represents a 17.34% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Neil J. Fernandes sold 7,659 shares of Lam Research stock in a transaction on Monday, June 1st. The stock was sold at an average price of $309.60, for a total value of $2,371,226.40. Following the sale, the senior vice president directly owned 58,470 shares of the company’s stock, valued at $18,102,312. This represents a 11.58% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 80,441 shares of company stock valued at $27,614,296 in the last ninety days. 0.31% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Several equities research analysts have issued reports on the stock. TD Cowen reiterated a “buy” rating and issued a $400.00 price target (up from $340.00) on shares of Lam Research in a research note on Thursday, July 9th. Oppenheimer reaffirmed an “outperform” rating and set a $400.00 price target (up from $330.00) on shares of Lam Research in a research report on Monday, June 15th. HSBC restated a “hold” rating and set a $333.00 target price on shares of Lam Research in a report on Monday, July 27th. Jefferies Financial Group set a $335.00 price target on shares of Lam Research and gave the stock a “buy” rating in a research report on Thursday, July 30th. Finally, UBS Group reiterated a “buy” rating and issued a $375.00 price target (up from $310.00) on shares of Lam Research in a research note on Tuesday, June 9th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $358.47.
Get Our Latest Analysis on Lam Research
Lam Research Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Further Reading
- Five stocks we like better than Lam Research
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
